Indo Us Biotech Ltd (INDOUS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 145.10
% Change: -0.96% (Prev Close: 146.50)

Volume: 2,312
% Change: -66.39% (Prev Volume: 6,879)

Delivery: 1,424
Delivery % : 61.59
% Change: -74.77% (Prev Delivery: 5,643)

Turnover: 3 Lacs
% Change: -66.76% (Prev Turnover: 10)

πŸ’Ή EOD Valuation

P/E Ratio: 16.36
P/B Ratio: 3.71
Market Cap: 292 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: INDOUS
Market Cap: 299 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 388.40
52 Week Low: 137.60

All-Time High: 388.40 Rs.
All-Time Low: 0.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-17.29% | -10.87% | -22.95% | -50.61% | 46.07%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 70.17%

Change (3Y | 1Y): -2.84% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 0.00%

Change (3Y | 1Y): 0.00% | 0.00%

DII Holding

DII Holding: 0.00%

Change (3Y | 1Y): 0.00% | 0.00%

Public Holding: 29.83%

🏦 Financial Strength

Debt to Equity: 0.19
Debt: 14.84 Rs. Cr.

Book Value: 39.16 Rs.
Current Ratio: 5.31
Interest Coverage: 12.28
Free Cash Flow: 0.56 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 40.14%

Sales Growth Qtr (YOY | QoQ):
24.47% | -7.82%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
21.17% | 28.12% | 40.14%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 96.79%

Profit Growth Qtr (YOY | QoQ):
48.26% | 27.72%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
44.98% | 45.89% | 96.79%

EPS Rs.

EPS (TTM): 8.87 Rs.

EPS Qtr (Last Year | Latest):
1.58 Rs. | 2.34 Rs.

EPS Annual (Last Annual | Annual March):
4.11 Rs. | 8.11 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
35.88% | 41.51%

Net Profit Rs. Cr.

Net Profit (TTM): 17.79 Rs. Cr.

Net Profit (Annual - March): 16.27 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
3.17| 3.68 | 4.70

EBITDA Rs. Cr.

EBITDA (Quarter): 5.47 Rs. Cr.
EBITDA (Previous Yr Ql): 3.72 Rs. Cr.

EBITDA (Annual - March): 19.12 Rs. Cr.
EBITDA (Previous Annual): 11.11 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
36.81% | 38.93%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 18.85%

OPM Qtr (Previous | Current):
13.72% | 17.78%

OPM Annual (5 Yrs | Last Yr | March):
15.77% | 14.81% | 18.24%

Return on Equity %

ROE: 23.03%

ROE (5 Yrs | 3 Yrs | Last Yr):
18.70% | 18.04% | 14.06%

Return on Capital Employed %

ROCE: 21.15%

ROCE (5 Yrs | 3 Yrs | Last Yr):
16.87% | 16.72% | 14.40%

Return on Assets %

ROA (TTM): 17.85%

ROA (5 Yrs | 3 Yrs | Last Yr):
12.75% | 13.38% | 10.71%

PEG Ratio: 0.37
Dividend Yield: 0.17%

PE 3 Yrs: 41.88
PE 5 Yrs: 24.85

Dividend Yield: 0.17%

πŸ‘₯ Company

Indo Us Biotech Ltd

INDOUS

Promoter Holding: %